Ticker
LENZCompany Name
LENZ THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -47.22M | -944.32% | $ 5M |
3/31/2025 | $ -51.5M | 0% | $ 0 |
12/31/2024 | $ -59.39M | 0% | $ 0 |
9/30/2024 | $ -96.19M | 0% | $ 0 |
6/30/2024 | $ -95.01M | 0% | $ 0 |
3/31/2024 | $ -92.87M | 0% | $ 0 |
12/31/2023 | $ -90.01M | 0% | $ 0 |
9/30/2023 | $ -66.56M | 0% | $ 0 |
6/30/2023 | $ -79.38M | 0% | $ 0 |
3/31/2023 | $ -87.81M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for LENZ THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -8.72M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.33% |
median | 12.67% |
std | 21.12% |